A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma
NCT05852028
·
clinicaltrials.gov ↗
UNKNOWN
Status
250
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma
DLBCL
T Cell Lymphoma
Interventions
DRUG:
Selinexor
Sponsor
Ruijin Hospital